154902-51-9

Basic information

• Product Name: BOC-L-3-BENZOTHIENYLALANINE
• Synonyms: RARECHEM BK PT 0204;N-ALPHA-T-BOC-BETA-(3-BENZOTHIENYL)-L-ALANINE;N-ALPHA-T-BUTOXYCARBONYL-3-(3-BENZOTHIENYL)-L-ALANINE;BOC-3-(3-BENZOTHIENYL)-L-ALANINE;BOC-L-3-BENZOTHIENYLALA;BOC-L-3-BENZOTHIENYLALANINE;BOC-L-3-(3-BENZOTHIENYL)ALANINE;BOC-BTA-OH
• CAS NO: 154902-51-9
• Molecular Formula: C₁₆H₁₉NO₄S
• Molecular Weight: 321.39
• Product Categories: Amino Acids;Phenylalanine analogs and other aromatic alpha amino acids;Amino Acid Derivatives;a-amino
• Mol File: 154902-51-9.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 514.1 °C at 760 mmHg
• Flash Point: 264.7 °C
• Appearance: /
• Density: 1.274 g/cm³
• Vapor Pressure: 2.56E-09mmHg at 25°C
• Refractive Index: 1.53
• Storage Temp.: -15°C
• PKA: 3.85±0.10(Predicted)
• BRN: 7081201
• CAS DataBase Reference: BOC-L-3-BENZOTHIENYLALANINE(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-L-3-BENZOTHIENYLALANINE(154902-51-9)
• EPA Substance Registry System: BOC-L-3-BENZOTHIENYLALANINE(154902-51-9)

Safety Data

• Hazard Codes: Xi
• WGK Germany: 3
• F: 10-23
• HazardClass: IRRITANT
• Hazardous Substances Data: 154902-51-9(Hazardous Substances Data)

Usage

General Description

BOC-L-3-benzothienylalanine is a chemical compound with the molecular formula C22H25NO4S. It is a derivative of the amino acid alanine, with an added BOC (tert-butyloxycarbonyl) protective group and a 3-benzothienyl substituent. BOC-L-3-BENZOTHIENYLALANINE is commonly used in the field of medicinal chemistry and drug development as a building block for the synthesis of peptide-based drugs and drug candidates. BOC-L-3-benzothienylalanine is a valuable tool for researchers working on the design and development of new pharmaceuticals, particularly those targeting diseases and conditions which involve protein-protein interactions.

InChI:InChI=1/C16H21NO4/c1-11(12-8-6-5-7-9-12)10-13(14(18)19)17-15(20)21-16(2,3)4/h5-9,13H,1,10H2,2-4H3,(H,17,20)(H,18,19)/t13-/m0/s1

Upstream product

• 23906-20-9 2-acetylamino-2-benzo[b]thiophen-3-yl-methyl-malonic acid diethyl ester 
• 63024-19-1 α-acetamido-β-<1>benzothiophene-3-ylpropionic acid 
• 3216-47-5 3-chloromethylbenzothiophene 
• 24424-99-5 di-tert-butyl dicarbonate 
• 72120-71-9 (S)-2-amino-3-<1>benzothiophene-3-ylpropionic acid 

Downstream Products

• 158574-74-4 N²-Boc-N-methyl-N-(phenylmethyl)-3-(3-benzothienyl)-L-alaninamide 
• 166519-79-5 (2S,4R)-2-[(S)-2-Benzo[b]thiophen-3-yl-1-(benzyl-methyl-carbamoyl)-ethylcarbamoyl]-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 473259-84-6 4-{(2S)-2-amino-3-[1-(2S)-2-benzo[b]thiophen-3-yl-1-benzylcarbamoylethylcarbamoyl-(2S)-2-biphenyl-4-yl-ethylcarbamoyl]-3(S)-sulfanylpropyl}benzoic acid 
• 473260-02-5 2-amino-N-(2-benzo[b]thiophen-3-yl-1-benzylcarbamoyl-ethyl)-3-biphenyl-4-yl-propionamide 
• 188728-87-2 (R)-N¹-((S)-2-Benzo[b]thiophen-3-yl-1-methylcarbamoyl-ethyl)-N⁴-benzyloxy-2-isobutyl-succinamide 

Relevant articles and documents

INHIBITORS OF AKT ACTIVITY

Invented are novel pyridine compounds, the use of such compounds as inhibitors of PKB/AKT kinase activity and in the treatment of cancer and arthritis.